Merlin Efraim

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 4

Top Topics

Combination Therapy

Advanced Non Small Cell Lung Cancer

Tyrosine Kinase

Ejection Fraction

Top Venues

The New England journal of medicine

Case reports in hematology

This page only lists publications with an associated author ORCID identifier.

Publications

David J Kuter, Jiří Mayer, Merlin Efraim, Lachezar H Bogdanov, Ross Ian Baker, Zane Kaplan, Mamta Garg, Marek Trněný, Philip Young-Ill Choi, Arend Jan Gerard Jansen, Vickie McDonald, Robert J Bird, Jaromir Gumulec, Milan Košťál, Terry Gernsheimer, Waleed Ghanima, Ahmed A Daak, Nichola Cooper
Long-term treatment with rilzabrutinib in patients with immune thrombocytopenia. Blood advances 8 (7) (2024)
David J Kuter, Jiří Mayer, Merlin Efraim, Lachezar H Bogdanov, Ross Ian Baker, Zane Kaplan, Mamta Garg, Marek Trněný, Philip Young-Ill Choi, Arend Jan Gerard Jansen, Vickie McDonald, Robert J Bird, Jaromir Gumulec, Milan Košťál, Terry Gernsheimer, Waleed Ghanima, Ahmed A Daak, Nichola Cooper
Long-term treatment with rilzabrutinib in patients with immune thrombocytopenia. Blood advances 8 (7) (2024)
David J Kuter, Merlin Efraim, Jiri Mayer, Marek Trněný, Vickie McDonald, Robert Bird, Thomas Regenbogen, Mamta Garg, Zane Kaplan, Nikolay Tzvetkov, Philip Young-Ill Choi, Arend Jan Gerard Jansen, Milan Kostal, Ross Baker, Jaromir Gumulec, Eun-Ju Lee, Ilona Cunningham, Isaac Goncalves, Margaret Warner, Ralph Boccia, Terry Gernsheimer, Waleed Ghanima, Olga Bandman, Regan Burns, Ann Neale, Dolca Thomas, Puneet Arora, Beiyao Zheng, Nichola Cooper
Rilzabrutinib, an Oral BTK Inhibitor, in Immune Thrombocytopenia. The New England journal of medicine 386 (15) (2022)
Ilina Micheva, Vladimir Gerov, Stela Dimitrova, Merlin Efraim
Efficacy of Inotuzumab Ozogamicin plus Ponatinib Followed by Allogeneic Stem Cell Transplantation in a Patient with Relapsed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia. Case reports in hematology 2021 (2021)